APA (7th ed.) Citation

Ruf, P., Kluge, M., Jäger, M., Burges, A., Volovat, C., Heiss, M. M., . . . Lindhofer, H. (2010). Pharmacokinetics, immunogenicity and bioactivity of the therapeutic antibody catumaxomab intraperitoneally administered to cancer patients. British journal of clinical pharmacology, 69(6), 617-625. https://doi.org/10.1111/j.1365-2125.2010.03635.x

Chicago Style (17th ed.) Citation

Ruf, Peter, et al. "Pharmacokinetics, Immunogenicity and Bioactivity of the Therapeutic Antibody Catumaxomab Intraperitoneally Administered to Cancer Patients." British Journal of Clinical Pharmacology 69, no. 6 (2010): 617-625. https://doi.org/10.1111/j.1365-2125.2010.03635.x.

MLA (9th ed.) Citation

Ruf, Peter, et al. "Pharmacokinetics, Immunogenicity and Bioactivity of the Therapeutic Antibody Catumaxomab Intraperitoneally Administered to Cancer Patients." British Journal of Clinical Pharmacology, vol. 69, no. 6, 2010, pp. 617-625, https://doi.org/10.1111/j.1365-2125.2010.03635.x.